BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Cardioxyl Pharmaceuticals 



Towson  Maryland    U.S.A.
Phone: Fax:


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
New Findings Published in Circulation: Heart Failure Show Potential Utility of Cardioxyl Pharmaceuticals's HNO Donors as Novel Treatments for Heart Failure 10/28/2013 10:58:44 AM    More...
Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., as Chief Medical Officer 9/11/2013 6:47:04 AM    More...
Cardioxyl Pharmaceuticals Raises $28 Million in Venture Funding 11/8/2012 9:07:45 AM    More...
Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 4/5/2011 6:53:14 AM    More...
Cardioxyl Pharmaceuticals Presents Data on its Clinical Candidate, Cxl-1020, at the 60th Annual American College of Cardiology Scientific Session 4/4/2011 2:23:51 PM    More...
Cardioxyl Pharmaceuticals Strengthens Executive Team by Appointing James Gilbert, M.D., as Chief Medical Officer 1/11/2011 6:42:29 AM    More...
Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients 8/26/2010 8:47:15 AM    More...
Cardioxyl Pharmaceuticals Announces Positive Results from First Clinical Study of its Lead Therapy, CXL-1020, in Heart Failure Patients; Cardioxyl Also Secures an Additional $15 Million in Funding 8/2/2010 7:05:37 AM    More...
Cardioxyl Pharmaceuticals' Data Presented at American College of Cardiology Annual Scientific Sessions 4/1/2010 9:49:34 AM    More...
Cardioxyl Pharmaceuticals Announces Pre-Clinical Results on Lead Clinical Candidate, CXL-1020 at American Heart Association Scientific Sessions 2009 11/18/2009 10:12:03 AM    More...
12

//-->